HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

YSL makeup artist

This article was originally published in The Rose Sheet

Executive Summary

Linda Cantello named artistic director for YSL color cosmetics, working closely with Creative Director Tom Ford and YSL Beaute President Chantal Roos to bring "modern, innovative sensibility" to the prestige beauty line, Gucci division announces. Makeup artist will create seasonal color collections, advise on new product initiatives and help develop new formulas. Cantello, who has worked as a runway makeup artist for more than 15 years, introduced her own beauty line in limited prestige distribution last year (1"The Rose Sheet" Feb. 26, 2001, p. 5)...

You may also be interested in...



Linda Cantello Cosmetics Expects Runway Show Color To Generate $3.5 Mil.

Makeup artist Linda Cantello has translated the "high fashion" of runway color cosmetics into makeup "for the real world" in her 100-SKU namesake cosmetics and skin care line, which is expected to generate $3.5 mil. in first-year sales, CEO and President Cathy Croddick Molyneux said.

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

 

 

Pipeline Watch: Phase III Readouts For Surufatinib, Tislelizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

UsernamePublicRestriction

Register

RS010191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel